In the present study, culture supernatants from larger granular lymphocytes (LGL) that were activated with Candida albicans antigens were shown to stimulate the ability of neutrophils to inhibit fungal growth. Identification of the activation factors showed that granulocyte-macrophage colony-stimulating factor (GM-CSF), a hematopoietic growth factor, was involved. Human peripheral blood mononuclear cells were fractionated by Percoll density centrifugation and each subpopulation of cells was stimulated with C albicans yeast cells. GM-CSF was produced in those fractions enriched for LGL, but not T lymphocytes or adherent mono-
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BLANCHARD, MICHELINI-NORRIS, AND DJEU mmoliL L-glutamine, 10 U1mL penicillin, 100 pg/mL streptomycin, 5 mmol1L HEPES buffer (GIBCO), and 5 x 1O-j molL 2-mercaptoethanol (Sigma Chemical Co, St Louis, MO), and will subsequently be referred to as complete medium. Plasticware was purchased from COSTAR (Cambridge, MA). Recombinant human GM-CSF (specific activity of 4 X lo7 colony-forming units [CFU] ) per mg protein) was a very generous gift from Dr Steven C. Clark (Genetics Institute, Cambridge, MA). All media contained less than 0.1 ndmL of endotoxin as determined by the Limulus Lysate assay (M.A. Biologics).
Preparation of monocytes. PBMC were incubated on gelatincoated tissue culture flasks for 1 hour at 37°C to allow adherence of monocyte^.^' Nonadherent cells (NAC) were recovered by vigorous washing of the flasks with warm medium and the adherent cells were removed by vigorous pipetting after the addition of cold PBS. Cells were then washed and resuspended in complete medium.
The separation of LGL from T cells was accomplished by the use of a discontinuous Percoll density gradient. NAC were further depleted of adherent cells and B cells by incubation on nylon wool columns for 30 minutes at 37°C. The cells passing through the columns were then placed on a six-step discontinuous density gradient with a range from 40% to 52.5% Percoll, as previously described.24 After centrifugation at 550g for 30 minutes at room temperature, the bands of lymphocytes were collected and examined for LGL morphology on Giemsa-stained cytocentrifuged slides. In this series of experiments, fractions 2 and 3 contained 70% to 80%
LGL and represented 10% to 15% of total peripheral blood lymphocytes (PBL).
To determine the phenotype of the cells responsible for GM-CSF production, 4 x lo6 washed LGL per treatment were pelleted in a 5-mL plastic tube. A previously determined optimal dilution of each monoclonal antibody (MoAb) was then added to the cell pellet and incubated for 20 minutes at 37°C. The MoAbs recognizing CD4, CD8, and CD11 were obtained from Ortho Pharmaceutical Corp (Raritan, NJ), and antibodies to CD15, CD16, and HLA-DR were obtained from Becton Dickinson Co (Mountain View, CA). Low-toxic rabbit complement (Cedarlane, Westbury, NY) was then added to the antibody-treated cells at a 1:10 dilution and incubated from an additional 45 minutes to effect lysis. Cells were examined for viability by trypan blue exclusion, washed twice in RPMI medium, and resuspended to the volume corresponding to the cell concentration of untreated LGL (2 x 10' cells1mL) without adjusting for nonviable cells to avoid enrichment of interfering cell populations in the experiments.
To obtain a purified population of LGL, CD16+ cells were isolated by panning, as described by Engleman et aL2' For this procedure, the 3G8 clone (anti-CD16, IgG1) was used and was generously provided by Dr J. Unkeless (Mount Sinai Medical School, New York, NY). Briefly, approximately 4 x lo7 LGL were incubated with 100 pg of purified anti-CD16 antibody for 20 minutes at room temperature. Unbound antibody was removed by washing twice with 5% fetal calf serum (FCS) in PBS. Cells were then resuspended in 5 mL of 5% FCS in PBS and incubated for 2 hours at 4°C on a large tissue culture flask previously coated with goat antimouse IgG (F(ab'), fragments; Sigma). Nonadherent cells (CD16-negative) were removed by four gentle washes with 1% FCS in PBS, and adherent cells (CD16-positive) were collected by vigorous pipetting with PBS. Cells were then washed with PBS and resuspended in medium for assay, as described. For these assays, 32% to 38% of CD16-coated cells from Percoll fractions 2 and 3 were nonadherent.
Leukocytes were cultured in 24-well tissue culture dishes at a concentration of 2 X 106 cells1mL with 1 mL per well. Heat-killed candida yeast cells were added at the indicated ratios and the cocultures were incubated for 1 to 7 days at Discontinuous Percoll density gradient centrifugation.
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Induction of GM-CSF:
37°C. Supernatant fluids were collected and passed through a 0.22-pm filter (COSTAR) to eliminate cell debris. Samples were either assayed immediately or were stored at -70°C.
The presence of CSF in supernatants was assayed using the human Mo7e cell line, which was established from the peripheral blood of a patient with acute megakaryocytic leukemia? This cell line was a generous gift from Dr Steven C. Clark (Genetics Institute) and is maintained in Dulbecco's modified Eagle's medium (DMEM; GIBCO) supplemented with 20% FCS (Hyclone Labs, Logan, UT), glutamine, penicillin, and streptomycin. Recombinant human IL-3 or GM-CSF is a required growth factor and is added at a final concentration of 8 UimL for continuous culture. For assay, Mo7e cells were washed twice with PBS, resuspended at a concentration of 1 X lo5 cells1mL in DMEM without growth factors, and 0.1 mL of the cell suspension was added to each well of a 96-well U-bottomed microtiter plate in which supernatant fluids were serially diluted in a final volume of 0.1 mL. Triplicate cultures for each dilution were incubated for 48 hours at 37°C and then pulsed with 0.5 pCi [methyl-'HI-thymidine (specific activity, 6.7 Ciimmol; ICN Pharmaceuticals, Irvine, CA) per well. The cultures were incubated an additional 18 hours, harvested, and counted in a beta scintillation counter. A standard curve using recombinant human GM-CSF was included with each assay and was used to calculate units of CSF activity in supernatant fluids.
To characterize the growth factor produced by LGL, supernatants that supported the growth of Mo7e cells were neutralized with sheep anti-recombinant human GM-CSF antibodies or rabbit anti-recombinant human IL-3 antibodies. All antibodies were generously provided by Genetics Institute. An excess amount of antibody was added to an aliquot of supernatant fluid, incubated at ambient temperature for 30 minutes, and then assayed for residual growth factor activity.
The NK assay was performed as described previo~s l y .~~ Briefly, K562 erythroleukemia cells were labelled with sodium [''Cr] chromate (Amersham Corp, Arlington Heights, IL), washed twice in PBS, and resuspended in complete medium at a concentration of 5 X lo4 cells/mL. K.562 cells were then added to 96-well microtiter plates at 0.1 mLiwell and used as target cells in a 4-hour "Cr-release assay with LGL as effector cells in E/T ratios varying from 20:l to 5:1. The spontaneous control was usually less than 15%, and the standard error was less than 5%. The percent NK activity was then calculated as follows:
Assay for GM-CSF.
NK assay.
(experimental cpm -spontaneous cpm) (total cpm -spontaneous cpm) x 100
Assayforgrowth inhibition ofC albicans. The optimal conditions for assessment of C albicans growth inhibition were as previously described.28 Briefly, PMN were diluted to 1 X lo6, 3 x lo5, and 1 x lo5 cells/mL in medium containing 1% FCS, and 0.05 mL of each dilution was added to triplicate wells of a 96-well flat-bottomed microplate. Then, 0.05 mL of C albicans at 1 X lo4 yeast cells1mL in 1% FCS-medium were added to all wells containing PMN, yielding E/T ratios of 10011, 3011, and 1011. Candida were also added to empty wells to serve as controls. Cell cocultures were incubated for 18 hours at 37°C and then pulsed with 0.05 mL of ['H]glucose (NET 807, D-[5,6-3H]glucose; New England Nuclear, Boston, MA) diluted to 10 pCi/mL in sterile water for an additional 3 hours of incubation. Candida1 growth was collected with a Skatron harvestor after the addition of 0.05 mL of 5.25% sodium hypochlorite to all wells. The mean of triplicate cultures was determined, and the standard error was within 5% of the mean. The percent growth inhibition (%GI) of C albicans was calculated as follows: %GI = (1 -[cpm of PMN and Candidaicpm Candida alone]) X 100.
For personal use only. on November 11, 2017. by guest www.bloodjournal.org From *PMN and Calbicans were incubated for 18 hours at 37°C at the indicated E/T ratios before [3H]glucose was added for an additional 3 hours for tThe indicated supernatants were added to the PMN in each well at a final 1 :lo0 dilution 30 minutes before Calbicans was added.
Supernatants were generated by incubating LGL in medium alone or in the presence of 10 Candida (Ca) heat-killed yeast cells per LGL for 2 days at radiolabel uptake into residual Candida. Data are representative of three experiments performed with similar results.
37°C.

RESULTS
Induction of PMN-activating factor from
LGL. We have previously shown that C albicans can stimulate LGL to produce both TNF and IFN-y, and that both of these cytokines are capable of augmenting the fungicidal activity of PMN.'* However, neutralization studies using anti-TNF and anti-IFN-y were unable to completely abrogate the stimulatory effect of LGL supernatants, leading to the speculation that CSF may be the unidentified PMNactivating factor. For this study, supernatants were generated by stimulating LGL with C albicans heat-killed yeast particles at a ratio of 10 yeasts per LGL for 2 days at 37°C. Supernatants from LGL incubated with medium alone were used as a control. As shown in Table 1 , only supernatants from Candida-stimulated LGL were capable of augmenting PMN fungicidal activity, from 9.7 to 40.1% GI at the 30/1 PMN to yeast ratio. However, when the supernatants were incubated with anti-GM-CSF before their addition to PMN, all PMN-activating activity was neutralized, indicating that the factor released by activated LGL was GM-CSF. Anti-IL-3, used as a control, had no effect on the supernatant activity. Furthermore, supernatants from either stimulated or control LGL had no direct effect on fungal growth, indicating that increased growth inhibition of Candida was mediated by activated PMN.
Effect of recombinant GM-CSF on PMNfungicidal activity. To confirm the stimulatory effect of GM-CSF on PMN, recombinant human GM-CSF was added to PMN 30 minutes before the addition of C albicans in a growth inhibition assay ( Table 2) . Although the native ability of the donors' PMN to inhibit the growth of Candida differed, the PMN of both donors were activated by the addition of as little as 0.1 U/mL of GM-CSF. Thus, PMN fungicidal activity can be enhanced by very small amounts of this cytokine.
In the above experiments, we have shown the presence of GM-CSF in stimulated LGL supernatants by negative selection, using specific antibodies that neutralize PMNactivating capacity of the supernatants. In the next series of experiments, the induction of GM-CSF from LGL was explored by the detection of known biologic function, ie, the ability to induce proliferation of a CSF-dependent hematopoietic cell line. The phenotype of the activated LGL and the conditions of optimal stimulation by Candida were characterized by using the Mo7e cell line to assess the biologic activity of supernatants from activated LGL under various conditions.
Before assessment of CSF activity with the Mo7e cell line, it was first necessary to establish their experimental sensitivity only to CSF, and not other unrelated cytokines. For this experiment, a variety of recombinant cytokines was serially diluted and added to Mo7e cells before measurement of cell proliferation ( Table 3) . Of the hematopoietic growth factors used, only GM-CSF and IL-3 were found to support the growth of Mo7e. G-CSF and M-CSF, which are reportedly required for differentiation of progenitor cells at a relatively late stage of their development,' were unable to maintain proliferation of this leukemic cell line. Because TNF is reportedly a growth factor for some cells, such as Dependence of Mo7eproliferation on CSF. fibr~blasts,~~ it was also assessed for this function with Mo7e. As shown, neither TNF nor other monokines, eg, IL-1 and IL-6, were found to support the growth of Mo7e cells. Alternatively, it was possible that TNF might be cytotoxic for these leukemic cells. Because we have shown that TNF can also be produced by Candida-stimulated LGL,'* it was important to determine whether this factor might mask the detection of CSF in the present assay. Table  3 shows that 1,000 U/mL of TNF had no effect on the proliferation of Mo7e induced by 10 U/mL of GM-CSF, indicating that the presence of TNF in LGL supernatants would not affect the detection of CSF by Mo7e cells. Induction of CSF by C albicans and the identijication of the CSF-producing cell population. To define which cells from normal peripheral blood responded to fungal antigens by producing hematopoietic growth factors, various subpopulations of PBL were isolated by adherence, to yield monocytes, and by Percoll fractionation, to separate LGL from T lymphocytes. The cell subpopulations were then similarly stimulated with C albicans for 3 days and their supernatants were collected and assessed for CSF content. As shown in Fig 1, PBL were found to respond to stimulation by CSF production. Fractionation of PBL into various subsets indicated that monocytes did not produce GM-CSF or IL-3 under such stimulation. CSF was also not found in the supernatants of T cells, which are isolated from Percoll fractions 4 through 7. However, cells from Percoll fractions 2 and 3, which contain the LGL subpopulation of lymphocytes, produced 42 and 67 U/mL of CSF activity, respectively, after 3 days of stimulation with Candida yeast cells.
The above experiments showed that C albicans was capable of inducing CSF from LGL within 3 days of culture. To determine the time course of growth factor production, LGL and monocytes were cocultured with Candida for 1 to 7 days before the supernatants were assayed for CSF. As shown in Fig 2, little CSF activity was seen in the supernatants of Candida-stimulated LGL until day 2 of culture. From that time, CSF continually increased throughout the 7 days of incubation. No CSF was seen in culture fluids of unstimulated LGL or unstimulated monocytes. Furthermore, only minimal levels of CSF (4 U/mL) were produced by stimulated monocytes compared with induced LGL (51 U/mL) after 7 days of incubation.
Kinetics of CSF production. Dose dependence of CSF production. To determine whether a dose response to the number of stimulating Candida yeast cells exists, LGL and monocytes were cultured with varying ratios of yeast to leukocyte, ranging from 0.3:l to 30:l (Fig 3) . As few as 1 yeast cell per 3 LGL was found to induce detectible levels of CSF. Optimal stimulation of LGL was found at a ratio of 3 Candida per lymphocyte, resulting in 53 U/mL after 3 days of incubation. As C albicans concentrations increase to 30:1, less CSF is produced, with levels decreasing to 19 U/mL. Alternatively, monocytes were not found to produce significant levels of CSF at any concentration of Candida.
Because Mo7e cells are shown to respond to both GM-CSF and IL-3, it was important to differentiate the type of CSF that was produced by Candida-stimulated LGL. For this experiment, supernatants that contained CSF activity were incubated with excess amounts of neutralizing antibody preparations and then assayed for residual growth factor activity. A s shown in Table 4 sheep antirecombinant human GM-CSF neutralized 97.8% of CSF activity, indicating that C albicans induced GM-CSF from LGL. On the other hand, rabbit antirecombinant human IL-3 minimally affected CSF activity in the LGL supernatants. The small decrease in activity by anti-IL-3 may be attributed to some crossreaction of this preparation with GM-CSF. This result can be seen by its ability to neutralize the proliferative activity of recombinant human GM-CSF by 15.4%. Due to the almost complete neutralization of CSF activity by anti-GM-CSF, the growth factor produced by stimulated LGL was identified as GM-CSF.
To determine the phenotype of the lymphocyte responsible for CSF production, LGL were serologically depleted of various subpopulations by incubation with MoAbs and complement to lyse the indicated phenotype. After complement depletion, the remaining LGL were stimulated with Candida for 3 days at a ratio of 3:l. An aliquot of LGL was also assessed for NK activity following complement depletion to determine if the CSF-producing LGL is associated with the subset known to display tumoricidal activity.
Treatment of LGL with anti-CD15 MoAbs, which depletes monocytes and macrophages, had only a slight effect on the production of CSF or on NK activity (Table 5) . Further treatment with anti-CD4 and anti-CD8, which lyse Phenotype of CSF-producing LGL.
T-helper and T-suppressor/cytotoxic lymphocyte subsets, respectively, did not affect CSF production, although NK activity was moderately decreased. Depletion of CD2-positive cells, which include T lymphocytes and LGL, abrogated both CSF production and NK activity. However, elimination of HLA-DR-positive LGL resulted in a loss of CSF activity, but NK-mediated lysis of K562 cells was not significantly affected. Finally, treatment of LGL with anti-CD16, which identifies NK cells, eliminated both CSF production and NK activity.
Because the use of complement plus anti-CD16 (Leu llb) antibodies did not efficiently eliminate LGL in the Percoll-enriched populations, a positive selection technique was also used to identify the cell population responsive to Candida. Cells were coated with anti-CD16 (3G8 clone) and then separated into CD16-positive and -negative phenotypes by panning on flasks coated with goat antimouse IgG. As shown in Table 6 , CD16-negative cells possessed neither NK activity nor the ability to produce CSF on stimulation with Candida, while both activities were seen within the CD16-positive population. Interestingly, treatment of LGL with anti-CD16 antibodies alone resulted in production of CSF, although in lower amounts than in the presence of Candida antigens. These results are similar to those of Cuturi et aI,l4 who reported that anti-CD16 (3G8) antibodies bound to Sepharose could For personal use only. on November 11, 2017. by guest www.bloodjournal.org From LGL were treated with the indicated antibodies plus complement and then incubated in medium alone or with Calbicans (Ca) at a ratio of 3:l for 3 days. NK assays were performed at the indicated E/T ratios of effector to K562 tumor target cell in a 4-hour "Cr-release assay. Data are representative of three experiments that were performed with similar results.
induce LGL to produce GM-CSF. Thus, from the positive and negative selection methods, the phenotype of the LGL that responded to stimulation by C albicans was CD2+, CD16+, and HLA-DR+.
DISCUSSION
PMN have been shown to be an important factor in resistance to opportunistic infection by Ca1bicamm Furthermore, their activity is sensitive to stimulation by a variety of cytokines, including IFN-y and TNF," and, as demonstrated in this study, GM-CSF. As little as 0.1 U/mL of recombinant GM-CSF was found to significantly enhance the ability of PMN to inhibit fungal growth. The purpose of this study was to understand the role of LGL, a potent source of such cytokines, in resistance to opportunistic infections.
In the present study, LGL, but not monocytes or small, mature T cells, were found to produce GM-CSF when directly stimulated with C albicans. As few as 1 yeast per 3 LGL could elicit sufficient levels of this cytokine to activate PMN fungicidal activity. Neutralization of CSF activity by anti-GM-CSF demonstrated that this factor was produced. While anti-IL-3 antibodies were found to decrease LGL supernatant-induced proliferation of Mo7e cells by 22%, the decrease was not significantly different from the neutralization of recombinant human GM-CSF by this preparation, demonstrating some crossreactivity existed. Although LGL have been shown to be capable of producing IL-3, only a combination of phorbol diester and calcium ionophore was effective in stimulating such prod~ction.'~ In our hands, only GM-CSF was produced by Candida-stimulated LGL.
Characterization of the LGL population responsible for CSF production showed that CD16+, HLA-DR+ cells were required. Interestingly, depletion of HLA-DR+ LGL did not adversely affect NK activity, but completely abrogated GM-CSF production. During these studies, all LGL were depleted of CD15+ cells to eliminate possible monocyte contamination before GM-CSF induction. Thus, the requirement for HLA-DR+ cells for CSF production indicates two possibilities. First, a small population of HLA-DR+ LGL may exist that would present antigen or otherwise stimulate HLA-DR-LGL, responsible for NK activity, to produce GM-CSF. Typically, only 5% to 10% of LGL were HLA-DR+ (Table 5) , and it seems unlikely that so few cells could produce large quantities of cytokine. This finding supports the notion that the HLA-DR+ LGL act as accessory cells for the HLA-DR-LGL, which produce GM-CSF. However, the second possibility suggests that an HLA-DR+ LGL population that itself possesses no spontaneous NK function may directly respond to Candida by GM-CSF release. Cuturi et all4 induced NK cells, which were expanded in vitro with B-lymphoblastoid cell stimulation, to produce GM-CSF. These initially HLA-DR-NK cells were found to become greater than 98% HLA-DR+. Another study, by Fitzgerald-Bocarsly et al,31 identified HLA-DR+ LGL as the source for IFN-a after stimulation with herpes simplex virus-infected fibroblasts. Thus, further studies are required to resolve the role of HLA-DR+ cells in GM-CSF, or other cytokine, production, particularly in relation to the cytolytic activity of LGL.
To date, most investigations on GM-CSF have centered on the hematopoietic effect of this cytokine because of its ability to stimulate colony formation in vitro. The importance of GM-CSF induction during microbial infection may lie in its ability to activate phagocytic cells to contain the microorganism. Our observation that GM-CSF is readily Cellsfrom Percoll fractions 2 and 3 were separated by panning into CD16-negative and -positive populations and then incubated in medium alone or with C albicans (Ca) at a ratio of 3: 1 for 3 days. NK assays were performed at the indicated E/T ratios of effector to K562 tumor target cell in a 4-hour "Cr-release assay. Data are representative of two experiments that were performed with similar results.
For personal use only. on November 11, 2017. by guest www.bloodjournal.org From induced by C albicans from LGL coupled with its ability to mobilize neutrophil or monocyte function, suggest that it may be a key CYtokine that Plays an important role in keeping this normally nonpathogenic organism under the control of LGL and phagocytes.
